Lana Medical Company (TADAWUL:9587)

Lana Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	139	132	160	115	-	-
Market Cap Growth	-14.29%	-17.57%	38.75%	-	-	-
Enterprise Value	164	141	161	120	-	-
Last Close Price	2.58	2.44	2.96	2.13	-	-
PE Ratio	51.67	48.87	12.83	-	-	-
PS Ratio	1.51	1.43	1.90	2.37	-	-
PB Ratio	2.14	2.02	2.62	2.36	-	-
P/TBV Ratio	2.14	2.03	2.63	2.37	-	-
P/OCF Ratio	-	-	406.51	112.52	-	-
EV/Sales Ratio	1.78	1.53	1.92	2.47	-	-
EV/EBITDA Ratio	15.03	13.71	14.43	107.83	-	-
EV/EBIT Ratio	31.53	23.67	19.03	-	-	-
Debt / Equity Ratio	0.45	0.45	0.25	0.23	0.16	0.21
Debt / EBITDA Ratio	2.49	2.49	1.29	7.11	0.94	1.04
Debt / FCF Ratio	-	-	-	-	15.15	-
Net Debt / Equity Ratio	0.38	0.38	0.15	-0.15	0.09	0.13
Net Debt / EBITDA Ratio	2.39	2.39	0.81	-6.67	0.56	0.65
Net Debt / FCF Ratio	-2.37	-2.37	-2.43	3.06	8.50	-0.43
Asset Turnover	0.79	0.79	0.94	0.70	0.68	-
Inventory Turnover	9.09	9.09	15.44	8.34	5.37	-
Quick Ratio	1.11	1.11	1.47	2.38	3.34	4.52
Current Ratio	1.58	1.58	1.87	3.03	4.16	5.39
Return on Equity (ROE)	4.28%	4.28%	22.70%	-4.00%	12.34%	-
Return on Assets (ROA)	3.16%	3.16%	5.92%	-0.33%	6.77%	-
Return on Invested Capital (ROIC)	4.77%	5.36%	13.93%	-0.79%	11.00%	13.24%
Return on Capital Employed (ROCE)	7.50%	7.50%	11.80%	-0.60%	12.40%	14.80%
Earnings Yield	1.94%	2.05%	7.80%	-1.67%	-	-
FCF Yield	-7.44%	-7.87%	-2.33%	-2.11%	-	-
Buyback Yield / Dilution	-	-	-18.38%	-1.37%	-37.11%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.